Non-Invasive Prenatal Testing (NIPT) is a screening method that evaluates the risk of common chromosomal abnormalities through a maternal blood sample from early pregnancy.

We offer structured counseling before and after testing to ensure accurate understanding of results. The Veracity test assesses risk for Trisomy 21, 18, and 13, as well as selected sex chromosome conditions.

Results are interpreted alongside ultrasound findings rather than in isolation. When increased risk is identified, diagnostic procedures are offered promptly and explained clearly.

Our screening pathway is organized, consistent, and integrated into overall pregnancy care. Clear communication and defined follow-up ensure informed decision-making and clinical precision.